Emmaus Life Sciences Probability of Future OTC Stock Price Finishing Over 0.26
| EMMADelisted Stock | USD 0.26 0.00 0.00% |
Emmaus |
Emmaus Life Target Price Odds to finish over 0.26
The tendency of Emmaus OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.26 | 90 days | 0.26 | about 72.78 |
Based on a normal probability distribution, the odds of Emmaus Life to move above the current price in 90 days from now is about 72.78 (This Emmaus Life Sciences probability density function shows the probability of Emmaus OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Emmaus Life Sciences has a beta of -1.36 suggesting as returns on its benchmark rise, returns on holding Emmaus Life Sciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Emmaus Life is expected to outperform its benchmark. Additionally Emmaus Life Sciences has an alpha of 0.2039, implying that it can generate a 0.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Emmaus Life Price Density |
| Price |
Predictive Modules for Emmaus Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Emmaus Life Sciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Emmaus Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Emmaus Life is not an exception. The market had few large corrections towards the Emmaus Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Emmaus Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Emmaus Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.20 | |
β | Beta against Dow Jones | -1.36 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.0033 |
Emmaus Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emmaus Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emmaus Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Emmaus Life Sciences is not yet fully synchronised with the market data | |
| Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
| Emmaus Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
| Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 39.0% of the company shares are held by company insiders |
Emmaus Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Emmaus OTC Stock often depends not only on the future outlook of the current and potential Emmaus Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Emmaus Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.3 M | |
| Cash And Short Term Investments | 2.3 M |
Emmaus Life Technical Analysis
Emmaus Life's future price can be derived by breaking down and analyzing its technical indicators over time. Emmaus OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Emmaus Life Sciences. In general, you should focus on analyzing Emmaus OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Emmaus Life Predictive Forecast Models
Emmaus Life's time-series forecasting models is one of many Emmaus Life's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Emmaus Life's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Emmaus Life Sciences
Checking the ongoing alerts about Emmaus Life for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Emmaus Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Emmaus Life Sciences is not yet fully synchronised with the market data | |
| Emmaus Life Sciences has some characteristics of a very speculative penny stock | |
| Emmaus Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| Emmaus Life Sciences currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 20.61 M. Net Loss for the year was (15.95 M) with profit before overhead, payroll, taxes, and interest of 17.3 M. | |
| Emmaus Life Sciences currently holds about 982 K in cash with (1.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 39.0% of the company shares are held by company insiders |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |